Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Journal of Zhejiang University. Science. B ; (12): 171-182, 2018.
Article in English | WPRIM | ID: wpr-1010378

ABSTRACT

The identification and use of molecular biomarkers have greatly improved the diagnosis and treatment of malignant tumors. However, a much deeper understanding of oncogenic proteins is needed for the benefit to cancer patients. The lipid raft marker proteins, flotillin-1 and flotillin-2, were first found in goldfish retinal ganglion cells during axon regeneration. They have since been found in a variety of cells, mainly on the inner surface of cell membranes, and not only act as a skeleton to provide a platform for protein-protein interactions, but also are involved in signal transduction, nerve regeneration, endocytosis, and lymphocyte activation. Previous studies have shown that flotillins are closely associated with tumor development, invasion, and metastasis. In this article, we review the functions of flotillins in relevant cell processes, their underlying mechanisms of action in a variety of tumors, and their potential applications to tumor molecular diagnosis and targeted therapy.


Subject(s)
Animals , Humans , Cell Differentiation , Endocytosis , Membrane Proteins/physiology , Neoplasms/etiology , Nerve Regeneration
2.
Journal of Central South University(Medical Sciences) ; (12): 1012-1018, 2008.
Article in Chinese | WPRIM | ID: wpr-814159

ABSTRACT

OBJECTIVE@#To determine the effect of activation of specific anti-tumor cytotoxic T lymphocytes (CTL) and the ability of cross-presentation in vitro by fusion of HLA-A2+ human dendritic cells (DCs) with HLA-A2- melanoma cells.@*METHODS@#The HLA-A2+ human dendritic cells and HLA-A2- melanoma cells were fused by PEG and were cultivated in complete RPMI1640 media containing FCS (10%) and GM-CSF for 24-48 h, and then co-cultured fusion cells with Melan-A specific T cells. HLA-A2- melanoma cells were negative control,While T2 cells and DC+Pts were positive control. The activation of anti-tumor CTL elicited by the fusion cells was detected by intracellular cytokine staining.@*RESULTS@#The immature DC could express CD80, CD83, CD86, HLA-DR, and HLA-ABC,but the mature DC induced by TNF-alpha, PGE-2, and CD40L further highly expressed above molecules. The rate of specific CTL cells primed by the fusion cells was 16.72%+/-4.26%, negative control was 0.21%+/-1.84%,and positive control was 28.60%+/-5.67%. The CTL from vaccine by fusing DC and LAR6 induced lysis of HLA-A2+ LAR1 cells.@*CONCLUSION@#The HLA-A2 restricted specific anti-tumor CTL can be induced in vitro by fusion of HLA-A2+ human dendritic cells with HLA-A2- melanoma cells.


Subject(s)
Humans , Antigen Presentation , Allergy and Immunology , Antigens, Neoplasm , Allergy and Immunology , Cancer Vaccines , Allergy and Immunology , Cell Fusion , Cell Line, Tumor , Dendritic Cells , Cell Biology , Allergy and Immunology , HLA-A2 Antigen , Allergy and Immunology , MART-1 Antigen , Allergy and Immunology , Melanoma , Allergy and Immunology , Pathology , T-Lymphocytes, Cytotoxic , Allergy and Immunology
SELECTION OF CITATIONS
SEARCH DETAIL